ArticlePathology oncology research : POR2012

Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma.

Xiaodong Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.